Abstract
Post-operative radiation and chemotherapy following diagnosis of astrocytoma are standard care. No research has examined racial or insurance-based disparities in treatment receipt. The purpose of this study was to evaluate whether African Americans and patients with dual eligibility in Medicare and Medicaid (DE), compared to Caucasians and patients with Medicare alone, experienced differences in (1) seeing a radiation oncologist, (2) receiving radiation or chemotherapy, and (3) overall survival. Using a retrospective descriptive design, statewide Medicaid and Medicare data were merged with the Michigan Tumor Registry to extract a sample of patients (n = 604) ≥65 years old with a first primary astrocytoma diagnosis in Michigan between 1996 and 2000. There were no racial or insurance-based differences in reporting a claim for a radiation oncologist. Controlling for age, income, surgical intervention, residence population, comorbidities, gender, and stage, African Americans were less likely to report radiation claims than Caucasians (OR = 0.20; 95% CI = 0.07–0.54). DE patients were less likely to report radiation claims (OR = 0.50; 95% CI = 0.26–0.94) than those with Medicare only. These differences were not seen with chemotherapy. When only those with a glioblastoma multiforme were examined, DE patients (OR = 0.47; 95% CI = 0.24–0.92) and African Americans (OR = 0.13; 95% CI = 0.04–0.44) were much less likely to report radiation claims. Race and insurance status did not significantly affect survival, although income did. Data suggest disparities in race and insurance status may exist in receiving standard of care for astrocytomas. Further research is warranted to replicate the data and determine potential sources for these disparities.
Similar content being viewed by others
References
CBTRUS (2008) Statistical report: primary brain tumors in the United States, 2000–2004. Central Brain Tumor Registry of the United States, Chicago
NCCN (2008) Central nervous system cancers, vol 1. National Comprehensive Cancer Network Inc
Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996
Kennedy J, Tuleu I, Mackay K (2008) Unfilled prescriptions of medicare beneficiaries: prevalence, reasons, and types of medicines prescribed. J Manag Care Pharm 14:553–560
Basu J (2001) Access to primary care: the role of race and income. J Health Soc Policy 13:57–73
McCall DT, Sauaia A, Hamman RF, Reusch JE, Barton P (2004) Are low-income elderly patients at risk for poor diabetes care? Diabetes Care May 27:1060–1065
Sambamoorthi U, Collins S, Crystal S (2001) Dually eligible individuals with AIDS: characteristics and health services use. J Health Soc Policy 14:19–35
Bradley CJ, Dahman B, Given CW (2008) Treatment and survival differences in older Medicare patients with lung cancer as compared with those who are dually eligible for Medicare and Medicaid. J Clin Oncol 26:5067–5073
Walsh EG, Clark WD (2002) Managed care and dually eligible beneficiaries: challenges in coordination. Health Care Financ Rev 24:63–82
Ryan J, Super N (2003) Dually eligible for Medicare and Medicaid: two for one or double jeopardy? Issue Brief Natl Health Policy Forum 794: 1–24
Groeneveld PW, Laufer SB, Garber AM (2005) Technology diffusion, hospital variation, and racial disparities among elderly Medicare beneficiaries: 1989–2000. Med Care 43:320–329
Mark TL, Axelsen KJ, Mucha L, Sadkova Y (2007) Racial differences in switching, augmentation, and titration of lipid-lowering agents by Medicare/Medicaid dual-eligible patients. Am J Manag Care 13(Suppl 3):S72–S79
Percy C, Shanmugratnam K, Whelan S, Parkin DM, Jack A, Fritz A, Sobin L (2005) ICD-O international classification of diseases for oncology, 3rd edn. World Health Organization, Switzerland
Buck C (2008) 2009 ICD-9-CM, vol 1, 2, & 3. Saunders, Philadelphia
Allison PD (2001) Missing data. Sage Publications, Thousand Oaks, CA
Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383
Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45:613–619
Klabunde CN, Potosky AL, Legler JM, Warren JL (2000) Development of a comorbidity index using physician claims data. J Clin Epidemiol 53:1258–1267
Baldwin LM, Klabunde CN, Green P, Barlow W, Wright G (2006) In search of the perfect comorbidity measure for use with administrative claims data: does it exist? Med Care 44:745–753
Keime-Guibert F, Chinot O, Taillandier L et al (2007) Radiotherapy for glioblastoma in the elderly. N Engl J Med 356:1527–1535
Magrini SM, Ricardi U, Santoni R et al (2006) Patterns of practice and survival in a retrospective analysis of 1722 adult astrocytoma patients treated between 1985 and 2001 in 12 Italian radiation oncology centers. Int J Radiat Oncol Biol Phys 65:788–799
Chang SM, Parney IF, Huang W et al (2005) Patterns of care for adults with newly diagnosed malignant glioma. JAMA 293:557–564
Zhang H, Kane RL, Dowd B, Feldman R (2008) Selection bias and utilization of the dual eligibles in Medicare and Medicaid HMOs. Health Serv Res
Carcaise-Edinboro P, Bradley CJ (2008) Influence of patient-provider communication on colorectal cancer screening. Med Care 46:738–745
Green AR, Peters-Lewis A, Percac-Lima S et al (2008) Barriers to screening colonoscopy for low-income Latino and white patients in an urban community health center. J Gen Intern Med 23:834–840
White A, Liu CC, Xia R et al (2008) Racial disparities and treatment trends in a large cohort of elderly African Americans and Caucasians with colorectal cancer, 1991 to 2002. Cancer 113:3400–3409
Kim SH, Ferrante J, Won BR, Hameed M (2008) Barriers to adequate follow-up during adjuvant therapy may be important factors in the worse outcome for Black women after breast cancer treatment. World J Surg Oncol 6:26
Morris AM, Billingsley KG, Hayanga AJ, Matthews B, Baldwin LM, Birkmeyer JD (2008) Residual treatment disparities after oncology referral for rectal cancer. J Natl Cancer Inst 100:738–744
Masi CM, Gehlert S (2009) Perceptions of breast cancer treatment among African-American women and men: implications for interventions. J Gen Intern Med 24:408–414
Barnholtz-Sloan JS, Williams VL, Maldonado JL et al (2008) Patterns of care and outcomes among elderly individuals with primary malignant astrocytoma. J Neurosurg 108:642–648
Robertson JT, Gunter BC, Somes GW (2002) Racial differences in the incidence of gliomas: a retrospective study from Memphis, Tennessee. Br J Neurosurg 16:562–566
Acknowledgements
This work was supported by the National Cancer Institute (R01-CA101835-01; C.J. Bradley, Principal Investigator).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sherwood, P.R., Dahman, B.A., Donovan, H.S. et al. Treatment disparities following the diagnosis of an astrocytoma. J Neurooncol 101, 67–74 (2011). https://doi.org/10.1007/s11060-010-0223-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-010-0223-8